Abatacept takes aim at rheumatoid arthritis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1501, 2005-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abatacept attains responses in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Abatacept a strong option for rheumatoid arthritis therapy

By  

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis: Clinical Experience with Abatacept

By Laganà Bruno   Vinciguerra Marta   D'Amelio Raffaele  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 185-202

Adis International

Access to resources Recommend Favorite

Model-based determination of abatacept exposure in support of the recommended dose for Japanese rheumatoid arthritis patients

By Hasegawa Mayumi  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 6, 2011-12 ,pp. : 803-832

Springer Publishing Company

Access to resources Recommend Favorite

Abatacept has a long-term AIM for treating RA

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite